Denise E Sampimon

Summary

Affiliation: Academic Medical Center
Country: The Netherlands

Publications

  1. doi Early diagnostic markers for encapsulating peritoneal sclerosis: a case-control study
    Denise E Sampimon
    Division of Nephrology, Department of Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Perit Dial Int 30:163-9. 2010
  2. doi The time course of peritoneal transport parameters in peritoneal dialysis patients who develop encapsulating peritoneal sclerosis
    Denise E Sampimon
    Department of Internal Medicine, Division of Nephrology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Nephrol Dial Transplant 26:291-8. 2011
  3. ncbi Does Alport syndrome affect the basement membrane of peritoneal vessels?
    Denise E Sampimon
    Department of Medicine, Division of Nephrology, Academic Medical Center, University of Amsterdam, Netherlands
    Adv Perit Dial 26:2-6. 2010
  4. ncbi Time course of peritoneal transport parameters in peritoneal dialysis patients who develop peritoneal sclerosis
    Denise E Sampimon
    Department of Internal Medicine, Division of Nephrology, Academic Medical Center, University of Amsterdam, Netherlands
    Adv Perit Dial 23:107-11. 2007
  5. doi Biological markers in the peritoneal dialysate effluent: are they useful
    Raymond T Krediet
    Department of Medicine, Academic Medical Centre University of Amsterdam, Amsterdam, The Netherlands
    Contrib Nephrol 163:54-9. 2009
  6. ncbi A two-hit approach in the development of an experimental peritoneal sclerosis model
    Anniek Vlijm
    Division of Nephrology, Department of Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Adv Perit Dial 28:26-31. 2012
  7. doi Risk factors associated with encapsulating peritoneal sclerosis in Dutch EPS study
    Mario R Korte
    Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands
    Perit Dial Int 31:269-78. 2011
  8. doi Experimental peritoneal sclerosis models should not be based on chlorhexidine gluconate anymore
    Anniek Vlijm
    Division of Nephrology, Department of Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Nephron Exp Nephrol 117:e1-8. 2011
  9. doi Encapsulating peritoneal sclerosis: the state of affairs
    Mario R Korte
    Albert Schweitzer Hospital, Department of Internal Medicine, PO Box 444, 3300 AK Dordrecht, The Netherlands
    Nat Rev Nephrol 7:528-38. 2011
  10. doi Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study
    Mario R Korte
    Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands
    Nephrol Dial Transplant 26:691-7. 2011

Detail Information

Publications10

  1. doi Early diagnostic markers for encapsulating peritoneal sclerosis: a case-control study
    Denise E Sampimon
    Division of Nephrology, Department of Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Perit Dial Int 30:163-9. 2010
    ..Therefore, we analyzed the time courses of the above described dialysate markers in EPS patients and controls...
  2. doi The time course of peritoneal transport parameters in peritoneal dialysis patients who develop encapsulating peritoneal sclerosis
    Denise E Sampimon
    Department of Internal Medicine, Division of Nephrology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Nephrol Dial Transplant 26:291-8. 2011
    ..The second aim was to identify specific peritoneal transport alterations that distinguish patients with UFF from patients who will develop EPS...
  3. ncbi Does Alport syndrome affect the basement membrane of peritoneal vessels?
    Denise E Sampimon
    Department of Medicine, Division of Nephrology, Academic Medical Center, University of Amsterdam, Netherlands
    Adv Perit Dial 26:2-6. 2010
    ..01). We could not confirm our hypothesis that Alport syndrome affects peritoneal solute clearances...
  4. ncbi Time course of peritoneal transport parameters in peritoneal dialysis patients who develop peritoneal sclerosis
    Denise E Sampimon
    Department of Internal Medicine, Division of Nephrology, Academic Medical Center, University of Amsterdam, Netherlands
    Adv Perit Dial 23:107-11. 2007
    ..It underlines the importance of regular assessment of peritoneal function with 3.86% peritoneal equilibration tests in every PD patient-not only those at risk for peritoneal membrane failure...
  5. doi Biological markers in the peritoneal dialysate effluent: are they useful
    Raymond T Krediet
    Department of Medicine, Academic Medical Centre University of Amsterdam, Amsterdam, The Netherlands
    Contrib Nephrol 163:54-9. 2009
    ....
  6. ncbi A two-hit approach in the development of an experimental peritoneal sclerosis model
    Anniek Vlijm
    Division of Nephrology, Department of Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Adv Perit Dial 28:26-31. 2012
    ..Besides renal failure and long-term exposure to bioincompatibleperitoneal dialysis solutions, a different second hit or several additional hits could be incorporated into an experimental model of EPS...
  7. doi Risk factors associated with encapsulating peritoneal sclerosis in Dutch EPS study
    Mario R Korte
    Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands
    Perit Dial Int 31:269-78. 2011
    ..The aim of the present study was to evaluate the independent associations of PD duration, age, dialysis fluids, and kidney transplantation with EPS...
  8. doi Experimental peritoneal sclerosis models should not be based on chlorhexidine gluconate anymore
    Anniek Vlijm
    Division of Nephrology, Department of Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Nephron Exp Nephrol 117:e1-8. 2011
    ..Our aim was to develop a chronic peritoneal infusion model of peritoneal sclerosis in rats with renal failure...
  9. doi Encapsulating peritoneal sclerosis: the state of affairs
    Mario R Korte
    Albert Schweitzer Hospital, Department of Internal Medicine, PO Box 444, 3300 AK Dordrecht, The Netherlands
    Nat Rev Nephrol 7:528-38. 2011
    ....
  10. doi Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study
    Mario R Korte
    Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands
    Nephrol Dial Transplant 26:691-7. 2011
    ..At present, there is no evidence for the effect of tamoxifen treatment in EPS patients. This study investigates the effect of treatment with tamoxifen on survival in EPS patients...